A few chemotherapeutic drugs have been reported to alter the tumor microenvironment to activate immune response,11,38 and increase the number of cytotoxic CD8+T cells within the tumor.39–41 Therefore, the key immune molecules involved in T cells activation, including co-stimulatory and co-inhibitory molecules were evaluated. Here, CD8A is linked to neoplasm.